Industry Focus

Can Amarin Corp Plc convert promise into profit? Motley Fool healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the challenges ahead for this volatile biotech stock.

Motley Fool Analysts Sean O’Reilly and Vincent Shen discuss the merits and drawbacks of investing in the movie theatre industry.

The competitive landscape of the financial industry has changed greatly over the last century – what does this mean for today’s banks?

Nintendo stock is making moves, while Glu Mobile’s Kim Kardashian: Hollywood game is climbing the iTunes charts. Motley Fool analysts Nathan Hamilton and Sean O’Reilly discuss why on this week’s Industry Focus Podcast.

A 742% spending surge for hepatitis C, pricey new diabetes medications, and one new drug class that has payers nervous -- all discussed today by healthcare analyst Michael Douglass and healthcare contributor Todd Campbell on today's Industry Focus.

Motley Fool Analysts Sean O’Reilly and Vincent Shen Dive into the international businesses of some of America’s most storied household brands.

Stress tests results reveal whether banks are prepared for economic downturn and if they can return more capital to shareholders.

It was a busy week as normal for tech stocks. Microsoft made a bold move, Intel shares slumped, and Amazon is jumping into the booming IoT industry. Fool analysts Nathan Hamilton and Sean O'Reilly discuss each news event and what it means for shareholders.

Today’s Industry Focus is talking Exxon, Chevron, and how not to fall prey to silly journalism in the energy space.

MannKind and Orexigen: two companies with big promise, but can they deliver on profit? Healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the risks facing these biotech stocks.

Are shares of Chipotle copy-cats becoming overvalued? Tune in to find out.

Initial bank stress tests results are out, and analysts discuss their importance and potential implications of this Wednesday’s round two results.

The tech world was focused on one event this past week – The Mobile World Congress. Held in Spain, the event serves as barometer of tech trends in coming years. Fool analysts Nathan Hamilton and Sean O’Reilly sit down to discuss the event and what it means for investors.

Healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the pitfalls and potential of two small cap biotech stocks.

Motley Fool analysts Sean O’Reilly and Vincent Shen discuss the global gaming industry and opportunities for investors.

Fool contributor John Maxfield takes on a few key points from this year’s letter to Berkshire Hathaway shareholders.

A lot has been said about the concerns and potential capabilities of AI. But how close is AI is to becoming reality? It may be farther out on the horizon than some believe.

With Seadrill and Transocean reporting earnings, some analysts out there are saying sell for some pretty ridiculous reasons. Here's why you shouldn't listen to them.

In this healthcare edition of Industry Focus, healthcare analyst Michael Douglass and healthcare contributor Todd Campbell speculate which of these two biotech titans is a better buy.

Join Motley Fool Analysts Sean O'Reilly and Vincent Shen for an investing happy hour as they discuss the alcohol industry.